are receiving ongoing care under the guidance of a healthcare professional skilled in the use of insulin and supported by the services of diabetes educator(s)
Because it is less frequently used, some people may not be as familiar with how to inject into this area safely
Weight Loss: LDN appears to contribute to weight loss by a number of mechanisms
SGLT2i use is associated with an increased risk of DKA and UTI, but confers several favourable outcomes, notably preservation of renal function, reduced risk of developing heart failure and CKD, and of hospitalisation, despite a higher prevalence of heart failure, hypertension, IHD and CKD at baseline
Supports a stronger, healthier immune system
Together, they blend WeightWatchers long-standing lifestyle approach with todays most effective, science-backed treatments for weight loss